Daniela Tomasoni

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• From access to action in transthyretin amyloid cardiomyopathy: are we missing opportunities for therapy optimization?
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuag220
  +Save
• Non-biopsy diagnosis of ATTR-CM: how safe is ‘non-invasive’?
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuag170
  +Save
• Beyond the gradient: patient-reported outcomes with aficamten in obstructive hypertrophic cardiomyopathy
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuag325
  +Save
• Definition and Prognosis of Mitral Regurgitation in Transthyretin Amyloid Cardiomyopathy: A Multicenter International Cohort Study
  Circulation 2026 DOI: 10.1161/CIRCULATIONAHA.125.079085
  +Save
• 2026 ESC Guidelines for the management of heart failure
  European Heart Journal 2026 DOI: 10.1093/eurheartj/ehag100
  +Save
• Acoramidis for ATTR cardiomyopathy: value, access, and the duty to treat
  European Heart Journal - Quality of Care and Clinical Outcomes 2026 DOI: 10.1093/ehjqcco/qcag101
  +Save
• Rethinking myocarditis and genetic susceptibility in severe paediatric cardiomyopathy
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuag201
  +Save
• Prevalence and prognostic role of untreated moderate-to-severe tricuspid regurgitation: a systematic review and meta-analysis
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuag192
  +Save
• What’s new in heart failure? February 2026
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuag107
  +Save
• Possible ways of building trial-level evidence for heart failure therapies in cardiac amyloidosis
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuag019
  +Save
• The Dyspnea Clinic: a new emerging interdisciplinary medical concept
  European Journal of Heart Failure 2026 DOI: 10.1093/ejhf/xuaf005
  +Save
• Sex differences in patients with advanced heart failure: an analysis of the HELP-HF registry
  ESC Heart Failure 2026 DOI: 10.1093/eschf/xvag004
  +Save
• Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy
  Journal of the American Heart Association 2025 DOI: 10.1161/JAHA.125.043049
  +Save
• Gamma-glutamyltransferase independently predicts mortality and heart failure hospitalization in cardiac transthyretin amyloidosis
  European Journal of Internal Medicine 2025 DOI: 10.1016/j.ejim.2025.06.009
  +Save
• Understanding the Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Heart Failure
  Cardiac Failure Review 2025 DOI: 10.15420/cfr.2025.10
  +Save
• What's New in Heart Failure? June 2025
  European Journal of Heart Failure 2025 DOI: 10.1002/ejhf.3737
  +Save
• Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions
  Marco Metra, Daniela Tomasoni, Marianna Adamo +11 more
  Circulation 2025 DOI: 10.1161/CIRCULATIONAHA.124.070411
  +Save
• Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCM
  Heart Failure Reviews 2024 DOI: 10.1007/s10741-024-10440-8
  +Save
• Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis
  European Heart Journal - Cardiovascular Imaging 2024 DOI: 10.1093/ehjci/jeae060
  +Save
• 2023 focused update of the 2021 ESC heart failure guidelines: Key messages for clinical practice
  European Journal of Clinical Investigation 2024 DOI: 10.1111/eci.14163
  +Save